Introduction
The incidence and related mortality rates of CRC in Saudi Arabia have been on a constant rise over the past twenty years (Mosli and Al-Ahwal, 2012) In 2010, AlHuzaim and his colleagues reported that CRC accounts for about 8.5% of all tumors in Saudi Arabia (Al-Huzaim cancers among males and the third among females (Sibiani et al., 2011) .
Poly(ADP-ribose) polymerase-1 (PARP-1) (EC
2.4.2.30)
catalyzes the conversion of nicotinamide adenine + ) to long branched adenosine diphosphate ribose polymers (PARs) and the addition of these PARs to target proteins as a post translational residues in AMD serve as acceptor sites for poly(ADPribosyl)ation (Yelamos et al., 2011) . PARP-1 contains a AMD that might be involved in homo-and/or heteromay allow the AMD to serve as a nucleic acid binding domain. This motif is found in the carboxylic-terminal of and Kraus, 2010) . The third domain is the carboxylterminal catalytic domain (CD) that catalyzes three ADP-ribose moiety onto an acceptor amino acid (initiation reaction), the addition of further ADP-ribose units onto already existing ones (elongation reaction), and the generation of branching points (branching reaction) (Ruf highly evolutionally conservative sequence that contains + acceptor site (Rouleau et al., 2010) .
The PARP-1 gene polymorphisms have been associated PARP-1, as well as differences in the levels of PARP-1 and cell tumor development and responses to chemo/radio-PARP-1 gene polymorphisms can aid in elucidating the role of PARP-1 in the development of different types of cancer and could potentially provide highly effective therapies for cancer that have increased sensitivity to PARP-1 inhibition (Bryant et al., 2005) .
PARP-1 mutations and susceptibility to develop CRC in was not hereditarily mutated in CRC. This study aims to (1) Study the genotype and allele frequencies of PARP-1 gene polymorphisms in patients with CRC and compare it with healthy subjects. (2) Evaluate the role of PARP-1 polymorphisms as predisposing factors for CRC in Saudi population.
Materials and Methods

Study population
CRC patients attended various clinics at King Khalid University Hospital, Riyadh, Saudi Arabia. The diagnosis of CRC was based on standard clinical, endoscopic, radiological, and histological criteria. Clinical and age at diagnosis, gender, and disease location. Blood sex-matched healthy individuals with no family history of CRC who attended the hospital for minor illnesses. The study was conducted after review and approval of the Institutional Review Board of the Ethics Committee at King Khalid University Hospital, Riyadh, Saudi Arabia.
Peripheral blood samples from all participants were was isolated from peripheral blood lymphocytes using using standard A260/A280 and A260/A230 ratios.
Polymerase chain reaction
Polymerase chain reactions (PCRs) were used to detect PARP-1 mL of each blood sample. All PCR assays were performed PH 8.3, 50 mmol/L KCl, 2 mmol/L MgCl 2 denaturing step at 95°C for 5 min followed by 35 cycles of denaturation at 95°C for 45 sec., annealing at 60°C for 1 min. (see Table 1 ), and extension at 72°C for 55 sec. All PCR reactions were followed by terminal extension step at 72°C for 7 min. Finally, the reactions were then held at 4°C until analysis. All PCR products were electrophoresed in agarose gel and visualized by ethidium bromide staining.
Sequencing reaction
In the present study we conducted a full sequence analysis of PARP-1 exons 3, 17, and 21. The mutant sites were screened and validated using Sanger Amersham, Sweden) and 2.5 µl of forward primers (with reaction volume of 20 µl. Cycle sequencing was carried out using veriti® thermocycler (Applied Biosystem, USA) for 25 cycles of 95°C for 20 sec., 52°C for 15 sec., and 60°C for 1 min. using ethanol precipitation protocol. Following this step the plate was ready to be subjected for sequencing by (American Laboratory Trading, USA). All samples with
Prediction of PARP-1 protein structure
Prediction of protein structure were done by discriminate the native from non-native models of the PARP-1 enzyme. The torsion angle potential over three consecutive amino acids was applied to analyze the local to recognize the native structure. The solvation free energy was calculated to discriminate the native protein structure from decoy ones, to describe the burial status of amino acids residues, and to study the effective energy surface of proteins in the solution that has a major determinant of protein stability. All-atom energy enables the scoring function to select a good protein model by measuring mutant PARP-1 enzyme on Lys933Asn and Lys945Asn.
MODEL and were viewed in Swiss-Pdb Viewer.
Statistical analysis
2 estimated to study the association between different PARP-1
Results
The demographic and clinical characteristics of the CRC patients are shown in Table 2 . The demographic data of controls were similar to those of the patients. Among the CRC patients, 34 (68%) were males and 16 (32%) were females and 76% of this population were above 50 years of age. The majority of the CRC patients have lower 28% of patients with rectum mass.
The PARP-1 Met129Thr T>C polymorphism in DBD number of control subjects. All the samples were homozygous for the wild type T allele and we could not able to detect a heterozygous T/A allele alteration that position (129), which was only found in a single CRC patient. The analyses of PARP-1 Met129Lys genotypes in Saudi CRC patients are presented in Table 3 . The OR for patients with the Met/Lys genotype versus the Met/ Met genotype was 3.0606 (p-value=0.4966, and 95% association between PARP-1 Met129Lys variant and CRC
Frequency of PARP-1 Val762Ala polymorphism
Allele and genotype frequencies of PARP-1 Val762Ala found in a single patient and was not detected in any of the controls. Two patients and one control subject were carried the heterozygote Val/Ala genotype. Our results (p-value 0.5540 for the heterozygous Val/Ala genotype and p-value 0.4885 for the mutant homozygous Ala/Ala genotype) show no association between PARP-1
Frequency of PARP-1 Lys940Arg polymorphism
detected in any of our samples, but we found another alteration, with a heterozygous A/C allele, that converts the lys940 to glutamine, in 16% of CRC patients and 12% of the control subjects. The genotype and allele frequencies patients and controls (see Table 5 ). However, we did genotype versus the Lys/Lys genotype, OR for patients ). According to our data no association was found between PARP-1 et al., 2000) . The loss of a methyl group from valine to alanine moves the 762 residue further away from its closest neighbor glutamine 888 (from 4.01A° for valine to 5.19A° for alanine), which in turn affects the PARP-1 enzymatic activity (Cottet et al., 2000) and thereby contributes to cancer susceptibility (Zaremba et al., 2009) .
It has been reported that PARP-1 Val762Ala polymorphism significantly contributes to lowering the PARP-1 catalytic activity by 30-40%, in a dosagedependent manner, which might diminishes the BER of the PARP-1 among ethnic populations. However, previous studies have between PARP-1 population, the same result was also found in Singapore Chinese population (Stern et al., 2007) . Although PARP-1 previous studies have investigated the association between PARP-1 Eastern countries, particularly in Saudi Arabia.
The mutant genotype for PARP-1 (2005) as alteration in exon 3 of the PARP-1 gene in both tumor and normal tissues of a single patient that causes amino acid substitution from methionine to thrionine study showed that the recognition and binding of PARPand cooperation between the first two zing fingers present in DBD of PARP-1 protein. It also suggested that specific in-trans interaction between ZnF I and ZnF II, which in turn leads to PARP-1 activation (Ali et al., 2012) . Another study proposed that recognition of to conformational changes in PARP-1 structure therefore enhances its activity (Langelier et al., 2012) . Exchange of a hydrophobic amino acid to polar one in DBD, namely 
Figure 1. Three Dimensional Structure of Native PARP-1 Protein and Mutated Models as Predicted by
Haplotype analysis of variations detected in PARP-1 gene
The haplotype frequencies for the Val762Ala, Lys945Asn alleles were estimated for the CRC patients and controls (see Table 7 ). A score for each haplotype (Hap-score) was calculated and the p-value was obtained 1-1-1-1-1-2, which only differed from the protective associated with CRC (OR 2.3736, 95% CI 1.0350-5.4436, and P 0.0412). All haplotypes containing more than one in the Saudi population.
Prediction of PARP-1 protein structure
Computer construction and analysis of protein models of the mutant PARP-1 enzyme (Figure 1 ) revealed that the mutant Lys933Asn PARP-1 protein had various changes energy different protein surface solvent-accessibility, and decreased C-beta interaction energy that might affect the binding ability of the enzyme to its substrate. The mutant Lys945Asn PARP-1 secondary structure, different protein surface solventaccessibility, and increased C-beta interaction energy that PARP-1
Discussion
reported in PARP-1 gene including 17 non-synonymous
PARP-1 gene that was
The Ala762 variant results from a base substitution from thymine to cytosine at codon 762 in exon 17 causing amino addition to that, a decreased in auto-poly(ADP-ribosyl) ation activity was observed in PARP-1 protein with germ-line tumor development and it has been proven to affect the response to chemotherapy (Ogino et al., 2010) .
but we were able to detect a heterozygous T/A allele alteration that converted the same amino acid to lysine found in one CRC sample while none of the controls carried the T/A allele. The lysine residue at codon 940 is a highly conserved amino acid located in the CD of the PARP-1 enzyme in which this residue may play a critical role in the enzyme structure. The substitution of lysine to arginine at position 940 results from a base transition from adenosine to guanine. The definite biological significance of this may affect the PARP-1 catalytic activity. Previous study agents in patients with lung cancer (Shiraishi et al., 2010) . gastric cancer in Chinese population (He et al., 2012) and CRC in Singapore Chinese (Stern et al., 2007) . Also it can contribute in the development of human germ cell tumors As we mentioned above this polymorphism was Chinese population (Stern et al., 2007) and that was the only study done to associate between the PARP-1 polymorphism, we found another alteration, with a heterozygous A/C allele, in 16% of the CRC patients and 12% of the control subjects. This alteration converts the lysine residue in position 940 to glutamine. This variation, which has not been reported before, may reduce the PAPR-+ ). Substitution of lysine reside with glutamate in the putative ATP-binding sequence of the RecD subunit of the RecBCD enzyme from Escherichia coli resulted in a reduction of the RecD activity. In addition, the mutant enzyme RecBCD has type enzyme (Korangy and Julin, 1992) .
Four novel mutations were detected that are located within the highly conservative CD, Only two of these alterations, namely Lys933Asn and Lys945Asn were (p-value=0.0318, OR=3.1429, and 95% CI=1.104-8.942 p-value=0.0257, OR=2.5714, and 95% CI=1.121-5.895 they both are located in PARP-1 CD, thus their substitution could affect the PARP-1 catalytic activity. Previous study showed that several lysine residues of PARP-1 protein can function as acceptor sites for enzymatic covalent autopoly(ADP-ribosyl)ation which can be present in AMD or outside this domain (Altmeyer et al., 2009 ). Mutations of these crucial lysine residues may be responsible for in carcinogenesis.
Protein models of the mutant PARP-1 protein show based on computer construction and analysis technology. This study provides further evidence for the important effect of the decoy PARP-1 on the pathogenesis of CRC. Our results showed limited association of PARP-1 polymorphisms with CRC which could be attributed to the limited number of samples that needs to be expanded PARP-1 in Saudi CRC patients is required to gather the full picture behind this protein and its full impact on CRC development. The novel detected alterations require full biochemical analysis to determine their actual effect on PARP-1 structure and function which can help in discovering its role in carcinogenesis. Association studies of PARP-1 gene with other types of cancer and to assess the role of different variations detected in PARP-1 gene with the development of CRC in Saudi population.
In conclusion, this study indicates that the previously PARP-1 gene namely, Met129Thr, Val762Ala, and Lys940Arg did not show any association novel alterations located in PARP-1 exon 21 were alterations encoded for amino acids located within the Among these novel alterations, only Lys933Asn and among Saudis. Further studies are required to determine the effect of the new alterations detected on PARP-1 enzymatic activity.
